Total Payments
$184,352
2024 Payments
$55,340
Companies
42
Transactions
1,681
Medicare Patients
5,418
Medicare Billing
$930,847
Payment Breakdown by Category
Other$143,444 (77.8%)
Food & Beverage$31,727 (17.2%)
Consulting$4,917 (2.7%)
Travel$3,111 (1.7%)
Education$1,152 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $143,444 | 101 | 77.8% |
| Food and Beverage | $31,727 | 1,536 | 17.2% |
| Consulting Fee | $4,917 | 5 | 2.7% |
| Travel and Lodging | $3,111 | 15 | 1.7% |
| Education | $1,152 | 24 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $96,181 | 319 | $0 (2024) |
| GENZYME CORPORATION | $31,893 | 70 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $20,818 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $13,859 | 303 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $4,955 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,650 | 131 | $0 (2024) |
| Amgen Inc. | $2,085 | 16 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,519 | 117 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,353 | 85 | $0 (2021) |
| Insmed, Inc. | $1,250 | 97 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,340 | 229 | AstraZeneca Pharmaceuticals LP ($39,107) |
| 2023 | $36,018 | 282 | AstraZeneca Pharmaceuticals LP ($14,068) |
| 2022 | $30,495 | 275 | AstraZeneca Pharmaceuticals LP ($14,614) |
| 2021 | $39,713 | 276 | AstraZeneca Pharmaceuticals LP ($22,880) |
| 2020 | $13,978 | 174 | GlaxoSmithKline, LLC. ($5,953) |
| 2019 | $3,061 | 178 | AstraZeneca Pharmaceuticals LP ($642.50) |
| 2018 | $2,716 | 137 | AstraZeneca Pharmaceuticals LP ($740.23) |
| 2017 | $3,030 | 130 | GlaxoSmithKline, LLC. ($1,118) |
All Payment Transactions
1,681 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Pulmonology | ||||||
| 12/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Pulmonology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $103.03 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Respiratory | ||||||
| 11/16/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Narcoplepsy | ||||||
| 11/15/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Narcoplepsy | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,669 | 2,840 | $704,787 | $241,641 |
| 2022 | 17 | 1,433 | 2,686 | $569,768 | $257,910 |
| 2021 | 17 | 1,214 | 2,151 | $486,658 | $262,334 |
| 2020 | 14 | 1,102 | 1,735 | $426,818 | $168,962 |
Total Patients
5,418
Total Services
9,412
Medicare Billing
$930,847
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 444 | 985 | $206,208 | $100,038 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 268 | 397 | $138,125 | $55,301 | 40.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 242 | 399 | $98,700 | $20,054 | 20.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 230 | 380 | $94,422 | $13,738 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $28,888 | $11,828 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $31,606 | $10,505 | 33.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 129 | 133 | $33,000 | $7,086 | 21.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 30 | 120 | $9,000 | $5,179 | 57.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $7,800 | $4,111 | 52.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 26 | 28 | $16,350 | $3,053 | 18.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 79 | $4,108 | $2,825 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 39 | $6,860 | $2,476 | 36.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 52 | $5,200 | $2,391 | 46.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $11,600 | $1,894 | 16.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 14 | 15 | $9,000 | $586.95 | 6.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 20 | 23 | $3,920 | $576.23 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 389 | 969 | $184,110 | $109,428 | 59.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 225 | 381 | $123,825 | $62,452 | 50.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 166 | 254 | $50,800 | $12,981 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $28,975 | $11,335 | 39.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 42 | 201 | $15,075 | $9,315 | 61.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $17,877 | $9,044 | 50.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 36 | 148 | $14,800 | $7,822 | 52.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 148 | 209 | $44,935 | $7,728 | 17.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 95 | 101 | $20,200 | $5,603 | 27.7% |
About Dr. Eric Teller, MD
Dr. Eric Teller, MD is a Critical Care Medicine healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700097326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Teller, MD has received a total of $184,352 in payments from pharmaceutical and medical device companies, with $55,340 received in 2024. These payments were reported across 1,681 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($143,444).
As a Medicare-enrolled provider, Teller has provided services to 5,418 Medicare beneficiaries, totaling 9,412 services with total Medicare billing of $930,847. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Geriatric Medicine, Pulmonary Disease
- Location Hackensack, NJ
- Active Since 05/25/2007
- Last Updated 09/25/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1700097326
Products in Payments
- DUPIXENT (Biological) $52,820
- BREZTRI (Drug) $46,142
- TEZSPIRE (Biological) $30,777
- FASENRA (Biological) $14,065
- NUCALA (Biological) $9,562
- QUVIVIQ (Drug) $4,955
- BREZTRI AEROSPHERE (Drug) $3,206
- TRELEGY ELLIPTA (Drug) $1,977
- Arikayce (Drug) $1,250
- ACTHAR (Biological) $1,173
- OFEV (Drug) $1,005
- FASENRA (Drug) $967.75
- STIOLTO RESPIMAT (Drug) $958.79
- XYWAV (Drug) $873.13
- BEVESPI AEROSPHERE (Drug) $711.22
- Wakix (Drug) $601.30
- LONHALA MAGNAIR (Drug) $575.54
- OPSUMIT (Drug) $542.67
- SYMBICORT (Drug) $466.87
- Esbriet (Biological) $393.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Hackensack
Dr. Raghad Said, Md, MD
Critical Care Medicine — Payments: $30,632
Critical Care Medicine $30,632
Eugene Bunnell, Md, MD
Critical Care Medicine — Payments: $6,225
Critical Care Medicine $6,225
Dr. Sean Mckay, M.d, M.D
Critical Care Medicine — Payments: $5,604
Critical Care Medicine $5,604
Dr. Fariborz Ashtyani, Md, MD
Critical Care Medicine — Payments: $4,361
Critical Care Medicine $4,361
Dr. Ronaldo Go, Md, MD
Critical Care Medicine — Payments: $1,618
Critical Care Medicine $1,618
Guido Barmaimon, M.d, M.D
Critical Care Medicine — Payments: $1,279
Critical Care Medicine $1,279